KIAA1522 is a novel prognostic biomarker in patients with non-small cell lung cancer

KIAA1522 is a novel prognostic biomarker in patients with non-small cell lung cancer

10.1038/srep24786

Saved in:

Bibliographic Details
Main Authors:	Liu, Y.-Z, Yang, H, Cao, J, Jiang, Y.-Y, Hao, J.-J, Xu, X, Cai, Y, Wang, M.-R
Other Authors:	CANCER SCIENCE INSTITUTE OF SINGAPORE
Format:	Article
Published:	2020
Subjects:	antineoplastic agent KRAS protein, human messenger RNA protein p21 tumor marker adult aged Carcinoma, Non-Small-Cell Lung female gene expression regulation genetics human Kaplan Meier method lung tumor male metabolism middle aged mortality prognosis proportional hazards model signal transduction treatment outcome Adult Aged Antineoplastic Combined Chemotherapy Protocols Biomarkers, Tumor Female Gene Expression Regulation, Neoplastic Humans Kaplan-Meier Estimate Lung Neoplasms Male Middle Aged Prognosis Proportional Hazards Models Proto-Oncogene Proteins p21(ras) RNA, Messenger Signal Transduction Treatment Outcome
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/178917
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Description
Summary:	10.1038/srep24786